Is Exact Sciences Corporation Stock a Buy?
Owning a stock that doubles in value in less than 11 months is exciting. But what word do you use for a stock that rises to 4.5 times its original price in that amount of time? Thrilling? Exhilarating? Whatever word is the best fit, it applies to Exact Sciences (NASDAQ: EXAS).
Everything that could go right seems to be doing so for the company behind the popular Cologuard DNA screening test for colorectal cancer. But with its rapid rise leading to a very lofty valuation, is Exact Sciences stock still one for investors to buy?
Image source: Getty Images.
Source: Fool.com
Exact Sciences Stock
€45.55
-0.040%
With 34 Buy predictions and not a single Sell prediction Exact Sciences is an absolute favorite of our community.
With a target price of 53 € there is a slightly positive potential of 16.37% for Exact Sciences compared to the current price of 45.55 €.
